Category: Prism View

Early today, Aytu BioPharma announced Fast Track Designation to AR101 for the treatment of Vascular Ehlers-Danlos Syndrome. As the news released, the stock surged around… [Read More]

Natus Medical (NTUS) investors see huge gains on Monday from news that the Company is being acquired by investment firm ArchiMed for approximately $1.2 billion…. [Read More]

Positive data supports company’s plans to seek FDA approval Global drug-delivery innovator Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) saw its stock price jump a… [Read More]

9 out of 10 stocks in the Emerging Uranium Index are up today, with Uranium Energy Corp. (UEC) leading the pack, finishing the day up… [Read More]

Antares Pharma (ATRS) surged 49% after agreeing to be bought by Halozyme Therapeutics in a cash deal valued at $960 million. About Antares Pharma Antares Pharma,… [Read More]

Qualigen Therapeutics (QLGN) leads the Prism Emerging MedDiagnostics Index with a 53% gain on the release of three posters at the American Association of Cancer… [Read More]

  Trinity Biotech (TRIB) has announced that it has secured a $45M equity plus debt investment in a partnership deal with Korean Biomedical Company MiCo…. [Read More]